TD Cowen Reiterates Buy on Ionis Pharmaceuticals, Maintains $108 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.6%

Neg 0% Neu 87.6% Pos 0%

TD Cowen analyst Yaron Werber reiterates Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and maintains $108 price target.